Intravesical interleukin-12 gene therapy in an orthotopic bladder cancer model

Urology

Volumn 66, Issue 2, 2005, Pages 461-466

  Horinaga, Minoru ^a   Harsch, Kelley M ^a   Fukuyama, Ryuichi ^a   Heston, Warren ^a   Larchian, William ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE; CANCER VACCINE; INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPSY; BLADDER CANCER; CANCER GRAFT; CANCER IMMUNOTHERAPY; CANCER MODEL; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GENE THERAPY; GENE TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR IMMUNITY;

ANIMALS; BCG VACCINE; FEMALE; GENE THERAPY; INTERLEUKIN-12; LIPOSOMES; MICE; NEOPLASM TRANSPLANTATION; URINARY BLADDER NEOPLASMS;

EID: 23744515341     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2005.03.052     Document Type: Article

References (30)

1. A. Jemal, R.C. Tiwari, T. Murray Cancer statistics, 2004 CA Cancer J Clin 54 2004 8 29
2. D. Raghavan, W.U. Shipley, M.B. Garnick Biology and management of bladder cancer N Engl J Med 322 1990 1129 1138
3. J.T. Hsieh, C.P. Dinney, L.W. Chung The potential role of gene therapy in the treatment of bladder cancer Urol Clin North Am 27 2000 103 113
4. P.B. Chapman, A.N. Houghton Non-antibody immunotherapy of cancer Curr Opin Immunol 5 1993 726 731
5. A. Bohle, S. Brandau Immune mechanisms in bacillus Calmette-Guérin immunotherapy for superficial bladder cancer J Urol 170 2003 964 969
6. T.L. Ratliff Role of animal models in understanding intravesical therapy with bacille Calmette-Guérin Clin Infect Dis 31 suppl 3 2000 S106 S108
7. T.L. Ratliff, J.K. Ritchey, J.J. Yuan T-cell subsets required for intravesical BCG immunotherapy for bladder cancer J Urol 150 1993 1018 1023
8. A.B. Alexandroff, A.M. Jackson, M.A. O'Donnell BCG immunotherapy of bladder cancer 20 years on Lancet 353 1999 1689 1694
9. J. Riemensberger, A. Bohle, S. Brandau IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer Clin Exp Immunol 127 2002 20 26
10. J. Tan, C.A. Newton, J.Y. Djeu Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model Cancer Res 56 1996 3399 3403
11. L. Chen, D. Chen, E. Block Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer J Immunol 159 1997 351 359
12. Z. Wang, S.J. Qiu, S.L. Ye Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma Cancer Gene Ther 8 2001 751 758
13. Y.L. Lee, M.H. Tao, Y.H. Chow Construction of vectors expressing bioactive heterodimeric and single-chain murine interleukin-12 for gene therapy Hum Gene Ther 9 1998 457 465
14. R.J. DeFatta, R.P. Chervenak, A. De Benedetti A cancer gene therapy approach through translational control of a suicide gene Cancer Gene Ther 9 2002 505 512
15. J.H. Felgner, R. Kumar, C.N. Sridhar Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations J Biol Chem 269 1994 2550 2561
16. Y. Horiguchi, W.A. Larchian, R. Kaplinsky Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model Gene Ther 7 2000 844 851
17. K. Yamanaka, I. Hara, H. Nagai Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model Cancer Immunol Immunother 48 1999 297 302
18. R. De Jager, P. Guinan, D. Lamm Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette Guérin overview analysis of six phase II clinical trials Urology 38 1991 507 513
19. M.A. O'Donnell, Y. Luo, S.E. Hunter Interleukin-12 immunotherapy of murine transitional cell carcinoma of the bladder dose dependent tumor eradication and generation of protective immunity J Urol 171 2004 1330 1335
20. P.U. Malmstrom, H. Wijkstrom, C. Lundholm Swedish-Norwegian Bladder Cancer Study Group 5-year followup of a randomized prospective study comparing mitomycin C and bacillus Calmette-Guérin in patients with superficial bladder carcinoma J Urol 161 1999 1124 1127
21. M. Ogawa, T. Tsutsui, J.P. Zou Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin 12 Cancer Res 57 1997 2216 2222
22. M.J. Brunda, L. Luistro, R.R. Warrier Antitumor and antimetastatic activity of interleukin 12 against murine tumors J Exp Med 178 1993 1223 1230
23. C.L. Nastala, H.D. Edington, T.G. McKinney Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production J Immunol 153 1994 1697 1706
24. M. Eto, M. Harada, K. Tamada Antitumor activity of interleukin-12 against murine bladder cancer J Urol 163 2000 1549 1552
25. T.S. Tzai, A.L. Shiau, C.L. Wu Postoperative administration of interleukin-12 significantly enhances the anti-tumor immune response of MBT-2 bladder cancer bearing mice Proc Natl Sci Counc Repub China B 24 2000 56 62
26. M.A. O'Donnell, Y. Luo, S.E. Hunter The essential role of interferon-gamma during interleukin-12 therapy for murine transitional cell carcinoma of the bladder J Urol 171 2004 1336 1342
27. S.K. Clinton, E. Canto, M.A. O'Donnell Interleukin-12 opportunities for the treatment of bladder cancer Urol Clin North Am 27 2000 147 155
28. W.F. Anderson Human gene therapy Nature 392 1998 25 30
29. M.J. Lee, S.S. Cho, J.R. You Intraperitoneal gene delivery mediated by a novel cationic liposome in a peritoneal disseminated ovarian cancer model Gene Ther 9 2002 859 866
30. M. Wood, P. Perrotte, E. Onishi Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse Cancer Gene Ther 6 1999 367 372